Melissa Nyendak, MD, MHS
Melissa Nyendak, MD, MHSAssistant Professor of Medicine
Division of Infectious Diseases, OHSU/VAMC
Degrees:
BS: University of Washington, Seattle, Washington 1995MHS: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 1999
MD: Sackler School of Medicine, Tel Aviv University; Tel Aviv, Israel 2002
Residency:
Internal Medicine, Oregon Health and Science University 2002-2005Fellowship:
Infectious Disease, OHSU 2005-2007
Clinical Interests:
- Mycobacterial infections
- Infections in immunocompromised hosts, specifically HIV patients.
Research Interests:
- Immunodiagnosis of Mycobacterium tuberculosis (Mtb) infection
- Immunological Bioinformatics
- Point of care diagnostics in high burden settings for Mtb
Publications:
- Lancioni C, Nyendak M, Kiguli S, et al. CD8+ T cells Provide an Immunologic Signature of Tuberculosis in Young Children. Am J Respir Crit Care Med 2011 Oct 27.
- Nyendak M, Lewinsohn DA, Lewinsohn DM. New diagnostic methods for tuberculosis. Curr Opin Infect Dis 2009 Apr;22(2):174-82.
- Nyendak M, Lewinsohn DA, Lewinsohn DM. The Use of Interferon-gamma Release Assays in Clinical Practice. Clinical Tuberculosis (P Davies Editor) Hodder Arnold Publication. (2008).
- Winthrop KL, Nyendak M, Calvet H, et al. Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008 Sep;3(5):1357-63.
